iifl-logo-icon 1

Vivo Bio Tech Ltd Share Price

37.66
(1.29%)
Jul 18, 2024|03:50:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open37
  • Day's High37.9
  • 52 Wk High56
  • Prev. Close37.18
  • Day's Low37
  • 52 Wk Low26.1
  • Turnover (lac)4.04
  • P/E22
  • Face Value10
  • Book Value36.49
  • EPS1.69
  • Mkt. Cap (Cr.)56.13
  • Div. Yield0
No Records Found

Vivo Bio Tech Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

37

Prev. Close

37.18

Turnover(Lac.)

4.04

Day's High

37.9

Day's Low

37

52 Week's High

56

52 Week's Low

26.1

Book Value

36.49

Face Value

10

Mkt Cap (₹ Cr.)

56.13

P/E

22

EPS

1.69

Divi. Yield

0

Vivo Bio Tech Ltd Corporate Action

1 Sep 2023

12:00 AM

BookCloser

arrow

18 Jun 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

31 Aug 2023

12:00 AM

AGM

Announcement Date: 31 Aug, 2023

arrow

Vivo Bio Tech Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Vivo Bio Tech Ltd SHAREHOLDING SNAPSHOT

18 Jul, 2024|10:53 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 42.08%

Foreign: 0.00%

Indian: 42.08%

Non-Promoter- 57.91%

Institutions: 0.00%

Non-Institutions: 57.91%

Custodian: 0.00%

Share Price

Vivo Bio Tech Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

14.9

14.95

14.85

12.89

Preference Capital

0

0

0

0

Reserves

36.97

32.19

27.7

20.15

Net Worth

51.87

47.14

42.55

33.04

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2020Mar-2018Mar-2017Mar-2016

Revenue

55.35

47

34.12

28.58

yoy growth (%)

17.76

37.72

19.39

60.68

Raw materials

-8.55

-9.56

-8.14

-8.79

As % of sales

15.45

20.35

23.86

30.78

Employee costs

-9.99

-7.58

-5.49

-4.34

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2020Mar-2018Mar-2017Mar-2016

Profit before tax

4.25

4

2.83

0.78

Depreciation

-5.17

-4.63

-3.9

-3.35

Tax paid

0.18

-0.88

-0.33

0.12

Working capital

8.28

4.54

4.71

8.12

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2020Mar-2018Mar-2017Mar-2016

Growth matrix (%)

Revenue growth

17.76

37.72

19.39

60.68

Op profit growth

14.62

42.61

105.79

32.15

EBIT growth

15.34

54.58

230.95

76.34

Net profit growth

42.28

24.72

175.16

96.62

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

45.45

52.23

51.39

51.78

55.35

Excise Duty

0

0

0

0

0

Net Sales

45.45

52.23

51.39

51.78

55.35

Other Operating Income

0

0

0

0

0

Other Income

0.04

0.04

0.1

0.08

0.05

Vivo Bio Tech Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,579.25

124.153,78,914.98867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,511.35

32.861,22,044.231,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,564.95

76.931,21,185.085310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,184.85

34.691,19,223.631,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,643.15

25.871,10,827.471,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Vivo Bio Tech Ltd

Management

Register Office

Registrar Office

Whole-time Director

Kalyan Ram Mangipudi

Whole-time Director

Alangudi Sankaranarayanan

Chairman & Independent Directo

K Sunder

Independent Director

Hariharan Ravindran

Independent Director

Kunda Kalpana

Director

Karopadi Shivanand Nayak

Whole Time Director & CFO

K Sri Kalyan

Additional Director

Shyam Sunder Tipparaju

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Vivo Bio Tech Limited, established in February, 1987 is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Their experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules.The Company stands as a premier and primary provider of SPF lab animals in India. It holds the distinction of being the largest breeder and distributor of rodent models, in addition to offering custom rodent models and stem cell products through Cyagen Biosciences. The Company serves as an authorized distributor of lab animal diets from Special Diets Services (UK) in India. It pioneered the commercial distribution of SPF guinea pigs, sourcing breeders from Elm Hill Labs (USA). Employing topquality SPF breed in their in-house lab animals, the Company upholds excellence in all pre clinical studies. Their comprehensive services span a wide array of preclinical toxicology disciplines, encompassing In-vitro and In-vivo studies, analytical chemistry studies, bioanalytical studies, and physico-chemical studies. Moreover, the Company boasts supplementary satellite facilities situated in Pregnapur Village, Siddipet District, Hyderabad, Telangana. The Biologic Research Services group at Vivo B
Read More

Company FAQs

What is the Vivo Bio Tech Ltd share price today?

Down Arrow

The Vivo Bio Tech Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹37.66 today.

What is the Market Cap of Vivo Bio Tech Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vivo Bio Tech Ltd is ₹56.13 Cr. as of 18 Jul ‘24

What is the PE and PB ratio of Vivo Bio Tech Ltd?

Down Arrow

The PE and PB ratios of Vivo Bio Tech Ltd is 22 and 1.02 as of 18 Jul ‘24

What is the 52 Week High and Low of Vivo Bio Tech Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Vivo Bio Tech Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vivo Bio Tech Ltd is ₹26.1 and ₹56 as of 18 Jul ‘24

What is the CAGR of Vivo Bio Tech Ltd?

Down Arrow

Vivo Bio Tech Ltd's CAGR for 5 Years at 1.22%, 3 Years at -24.83%, 1 Year at 37.35%, 6 Month at -6.89%, 3 Month at -16.75% and 1 Month at -7.47%.

What is the shareholding pattern of Vivo Bio Tech Ltd?

Down Arrow

The shareholding pattern of Vivo Bio Tech Ltd is as follows:
Promoters - 42.08 %
Institutions - 0.00 %
Public - 57.92 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.